109 results about "Fat body metabolism" patented technology

Provided herein are methods for determining the metabolism of one or more sugars and / or fatty acids, and applications thereof. Such applications include determining the rate of glycogen synthesis and glycolysis, which are believed to be early markers for predicting elevated risk of diabetes and cardiovascular disease. Other applications include methods for screening drugs that effect sugar and / or fatty acid metabolism. The methods are useful for at least partially characterizing drugs for desirable or undesirable (toxic) characteristics. Drugs that are at least partially characterized using the methods of the invention can then be further developed in pre-clinical testing and clinical trials. Such drugs may be found to be useful in treating obesity, diabetes, cardiovascular disease, and other disorders of metabolism.

The patent relates to a health products having slimming food, which taking natural medicine lotus leaves, aqueous extract of phyllanthus as raw material, adding l-carnitine and mixing them by a certain proportion to forming effervescent and granules. The invention has functions of stopping fat absorption, anti-aging, anti-oxidation and so on and regulating body environment and supplementing natural vitamin, aminophenol and microelement, which is capable realizing losing weight and life-prolonging ideal effect though long-term taking.

The present invention relates to soluble dimeric double metal salt compositions of (−)-hydroxycitric acid (“HCA”), as well as methods for making and using the same. The invention provides dimeric double metal salts of group IA and IIA of HCA (hereinafter, “DDM-HCAs”). The present invention provides methods to make DDM-HCAs of the invention which can be employed to alter the polar / ionic qualities of HCA salts and derivatives to improve solubility of HCA compositions. DDM-HCAs of the invention are soluble HCA-containing compositions useful as dietary supplements and suitable for manipulations under those conditions necessary for tabletting, encapsulation, and the production of dry powders, particularly for use as a beverage premix. Methods of use of the composition include treatment for suppression of appetite, for weight loss, for an increase in the rate of fat metabolism, for reduction in blood lipids and postprandial lipemia, and to increase the plasma level of (−)-hydroxycitric acid.

The present invention relates to the technical field of medicine, particularly to an application of a glucosamine salt. The weight reduction and / or fat reduction drug prepared by adopting the glucosamine salt, especially the drug with effects of weight reduction and fat reduction, provides significant application effects in fields of weight control, appetite ensuring, body fat reduction and liver fat metabolism acceleration. Application research results show that the glucosamine hydrochloride provides more excellent corresponding effects compared with the glucosamine sulfate. The present invention provides the new application of the glucosamine salt, wherein the glucosamine salt has effects of significant weight reduction, significant fat reduction, fatty liver alleviating and serum blood fat reduction.

A quantitative, non-invasive optical spectroscopy technique for measuring dynamic changes in adipose tissue structure and metabolism in vivo. The technique requires multiple wavelengths of light in the near-infrared (650-1000 nm). Using these wavelengths of light, adipose tissue is illuminated and light that returns to a photodetector is analyzed. From the return signals, the absorption and reduced scattering coefficients (μa and μs′) at each wavelength are calculated. The obtained pa and μs′ values allow for quantification of biomarkers and indices which allow for measurement of fat composition and metabolism. The concentration of oxy- and deoxy-hemoglobin, the fractional water and lipid content, and information about the size distribution of light scatterers in the adipose tissue are also determined. A detailed and quantitative understanding of fat composition and metabolism is thereby provided which describes the effectiveness of interventions to improve the health of a patient.

The invention provides application of gypenoside-XLIX to preparation of medicine for improving the liver fat metabolism. The medicine is used for preventing and / or treating relevant diseases caused byliver fat metabolism disorder. By building a cell model of non-alcoholic fatty liver diseases, the effect of the gypenoside-XLIX of obviously improving the liver fat metabolism is proved. Through experiments, the effects that the gypenoside-XLIX can be used for reducing the content of triglyceride in the liver cells, reducing the fat accumulation in the liver cells, and regulating down the SCD1 transcriptional level expression to relieve the liver fat metabolism disorder are discovered. Therefore, the gypenoside-XLIX has an important effect on the prevention and treatment of the non-alcoholicfatty liver diseases.

The invention discloses a mixture of black fungi, royal jelly and giant salamander full powder and a preparation method thereof. The black fungi, the royal jelly and the giant salamander full powder in the mixture are nanometer fine powder, and the black fungi fine powder accounts for 10 to 30 percent, the royal jelly fine powder accounts for 10 to 30 percent and the giant salamander full powder accounts for 10 to 80 percent in percentage by weight. The preparation method comprises the following steps of: after being sterilized, the black fungi are ground into nanometer fine powder; after being processed by vacuum freeze drying, the royal jelly is ground into nanometer fine powder; after lungs and intestinal tract organs are removed, live giant salamander is processed by vacuum freezing, drying and pulverization and then ground into nanometer fine powder; and the thee kinds of powders are proportionally mixed to prepare the product. The mixture is rich in vitamin, protein, iron and other microelements as well as unsaturated fatty acid and amino acid, has comprehensive nutrition ingredients and reasonable proportion, meets the requirements of the food pyramid and is the nutrient health care product capable of reducing blood-fat and blood viscosity, reducing blood sugar in an auxiliary manner, balancing fat metabolism, glycometabolism, and the like and being convenient to take.

The invention relates to jelly containing soybean peptides and a preparation method of the jelly. The jelly is prepared from the following raw materials in percentage by weight: 2-8% of soybean peptides, 1-10% of jelly powder, 2-3% of pectin, 1-2% of carrageenin and the balance of water. The jelly has the physiological regulation effects of reducing blood fat, reducing cholesterol, reducing blood pressure, promoting absorption of mineral substances, promoting fat metabolism and the like.

A composition comprising (a) and (b), and a food or drink or a medicine comprising the composition, wherein(a) is at least a kind of polyphenols selected from the group consisting of a polyphenol containing 15 mass % or more of proanthocyanidin having a polymerization degree of 1 to 3, hesperidin, a hesperidin derivative, and hesperetin; and(b) is at least a kind of xanthine derivatives, the mass ratio of (a):(b) in the composition being 1:(0.001 to 5), are useful for the prevention, amelioration, or treatment of metabolic syndrome, disorders of lipid metabolism (for example, fatty liver, hyperlipidemia), obesity (for example, visceral fat accumulation, subcutaneous fat accumulation), or the like.

A quantitative, non-invasive optical spectroscopy technique for measuring dynamic changes in adipose tissue structure and metabolism in vivo. The technique requires multiple wavelengths of light in the near-infrared (650-1000 nm). Using these wavelengths of light, adipose tissue is illuminated and light that returns to a photodetector is analyzed. From the return signals, the absorption and reduced scattering coefficients (μa and μs′) at each wavelength are calculated. The obtained μa and μs′ values allow for quantification of biomarkers and indices which allow for measurement of fat composition and metabolism. The concentration of oxy- and deoxy-hemoglobin, the fractional water and lipid content, and information about the size distribution of light scatterers in the adipose tissue are also determined. A detailed and quantitative understanding of fat composition and metabolism is thereby provided which describes the effectiveness of interventions to improve the health of a patient.

The invention relates to a method for preparing peony pollen protein polypeptide by using peony pollen as a raw material, the peony pollen protein polypeptide prepared by the method, and the application of the protein polypeptide. The peony pollen protein polypeptide of the present invention is a peony pollen protein, or a peony pollen polypeptide. The dried peony pollen is used as a raw material, and the peony pollen protein is obtained through pollen wall breaking, crude protein extraction, and vacuum drying; the peony pollen protein is subjected to proteolysis, debittering, decolorization, centrifugation or filtration to obtain peony pollen polypeptide. The product can be in the form of powder, granule, tablet, capsule, oral liquid and the like. Peony protein polypeptide has the advantages of lowering cholesterol, lowering blood pressure, promoting fat metabolism, anti-fatigue, enhancing human immunity, regulating human physiological functions, etc. It has broad development and application prospects in the fields of food industry, health care and medicine.

The invention discloses a leiocassis longirostris feed capable of increasing the fat utilization rate. The leiocassis longirostris feed is prepared from the following components in parts by weight: 50-78 parts of a plant powder component, 21-38 parts of an animal protein powder component, 6-14 parts of a grease component, 2.71-4.53 parts of a nutrient component, 0.02-0.05 part of bile acid, 0.01-0.02 part of L-carnitine, 0.1-0.3 part of methionine, 0.1-0.3 part of choline chloride, 0.01-0.02 part of an antioxidant namely acridon and 0.1-0.3 part of crystal lysine. According to the leiocassis longirostris feed capable of increasing the fat utilization rate disclosed by the invention, the quantity of saturated fatty acids is reduced, and the variety quantity of high-quality grease including soybean oil, fish oil, phosphatide oil and the like is added, so that polyunsaturated fatty acids required for rapid growth of leiocassis longirostris are provided; in accordance with the problem of digestive disorder of fish bodies after the addition quantity of fat is increased, an emulsifying agent and the bile acid are added, so that the emulsifying function is strengthened, and the digestive absorption of the fat is promoted; and in accordance with the decomposition energy supply of the fatty acids, micronutrient namely the L-carnitine for promoting fat metabolism energy supply is added.

The invention discloses a premix for body shape improvement and meat quality improvement of growing-finishing pigs, which is prepared from the following raw materials in percentage by mass: 8 to 12 percent of phytosterol, 15 to 25 percent of bioactive peptide, 40 to 60 percent of betaine, 8 to 12 percent of fructus perillae extract and 8 to 12 percent of compound amino acid. After the feed is used for a period of time, the body shape of growing-finishing pigs is obviously improved, the growth speed is obviously increased, and the meat quality is obviously improved after slaughtering. The components in the formula have a synergistic effect in the aspects of growth hormone secretion regulation and control, muscle growth mechanism regulation and control, fat metabolism redistribution, body antioxidation, muscle growth amino acid supply and the like, and the problems that the body shape of the growing-finishing pigs is not obviously improved and the meat quality is reduced are jointly solved.